Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

3,895 total articles

CAPZA secures nearly €1.4bn at first close of Private Debt 7

CAPZA secures nearly €1.4bn at first close of Private Debt 7

CAPZA, part of BNP Paribas Asset Management Alternatives (EURONEXT:BNP), announced the first closing of its CAPZA Private Debt 7 fund with almost 1.4 billion euros in commitments. The initial raise already exceeds half of the capital collected for the preceding fund and draws significant participation from both returning partners and new investors,…

ReNew Energy Posts Strong Q3 as Adjusted Ebitda Jumps 54%

ReNew Energy Posts Strong Q3 as Adjusted Ebitda Jumps 54%

ReNew Energy reported a 54% year-over-year rise in adjusted Ebitda for the third quarter, delivering 21.38 billion rupees and beating analyst expectations of 17.05 billion rupees. Revenue climbed 36% to 25.14 billion rupees. The company raised the lower bound of its fiscal 2026 adjusted Ebitda guidance to a range of 90 billion to 93 billion rupees,…

Alibaba Launches Qwen3.5, Positioning Model for 'Agentic AI' Workloads

Alibaba Launches Qwen3.5, Positioning Model for 'Agentic AI' Workloads

Alibaba on Feb 16 introduced Qwen3.5, an AI model engineered to carry out complex tasks autonomously. The company says the model is significantly cheaper and faster on heavy workloads than its predecessor, adds visual agentic features for taking actions across apps, and shows benchmark advantages over several leading U.S. models. The move comes ami…

Physiomics posts 51% H1 revenue rise as it debuts Biometrics service

Physiomics posts 51% H1 revenue rise as it debuts Biometrics service

UK data science firm Physiomics reported a 51% year-on-year increase in first-half revenue to £498,000, its strongest six-month intake to date. Despite the revenue milestone, the company recorded a wider operating loss driven by onboarding and contractor costs. The firm launched a new Biometrics service line during the period, securing four initial…

European shares creep higher as financials gain ahead of industrial data

European shares creep higher as financials gain ahead of industrial data

European equities moved modestly higher on Monday with financial stocks providing the main lift. The STOXX 600 index rose 0.3% to 619.74 by 0810 GMT, led in part by gains in Spain’s bank-heavy benchmark. Investors are preparing for several corporate earnings reports later in the week and a euro zone industrial production read that is expected to sh…

Jefferies Raises ACS to Buy, Sees Unpriced Value in Greenfield Data-Center and Express-Lane Projects

Jefferies Raises ACS to Buy, Sees Unpriced Value in Greenfield Data-Center and Express-Lane Projects

Jefferies upgraded ACS from hold to buy and lifted its price target to €116, saying the market is not fully valuing the company's greenfield infrastructure pipeline. The brokerage's revised sum-of-the-parts model explicitly incorporates secured data-center capacity and the U.S. SR-400 express-lane project, producing an implied equity stub roughly €…

Tokyo stocks dip as sector losses outweigh gains; Nikkei 225 slips 0.22%

Tokyo stocks dip as sector losses outweigh gains; Nikkei 225 slips 0.22%

Japan's equity market closed modestly lower on Monday, with the Nikkei 225 ending down 0.22% as declines in the Paper & Pulp, Transport and Communication sectors outweighed gains in several individual stocks. Market breadth was positive but notable individual moves pushed some large-cap names sharply higher and others sharply lower. Volatility edge…

Olympus Shares Plunge After Firm Lowers Full-Year Profit Forecast

Olympus Shares Plunge After Firm Lowers Full-Year Profit Forecast

Olympus Corp. saw its stock tumble after revising down its fiscal net profit forecast and reporting a decline in adjusted quarterly profit. The company cited higher expenses, weaker U.S. sales of gastrointestinal endoscopes and voluntary shipment suspensions following U.S. FDA re-inspections as factors driving the cut.